Top 30 Medical VC Funds & Investors in New Zealand (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Icehouse Ventures
VC Fund
|
7 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $650k–$19M |
|
Uniservices
VC Fund
|
5 | New Zealand, United States, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Medical Device, Manufacturing | $283k–$8.4M |
|
Matū Group
VC Fund
|
4 | New Zealand, Australia, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Manufacturing | $337k–$25M |
|
Pacific Channel
VC Fund
|
3 | New Zealand, Australia, United States | Seed, Venture - Series Unknown, Pre-Seed | Manufacturing, Health Care, Biotechnology | $511k–$5.5M |
|
IP Group
VC Fund
|
3 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$30M |
|
Global from Day One
VC Fund
|
3 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Medical Device | $694k–$18M |
|
New Zealand Growth Capital Partners
VC Fund
|
3 | New Zealand, United States, Australia | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Medical Device | $435k–$17M |
|
Enterprise Angels
VC Fund
|
3 | New Zealand, United States, United Kingdom | Seed, Angel | Software, Information Technology, Health Care | $229k–$4.3M |
|
Flying Kiwi Angels
VC Fund
|
2 | New Zealand, United States | Seed, Angel, Pre-Seed | Software, Information Technology, Apps | $334k–$4.3M |
|
Movac
VC Fund
|
2 | New Zealand, United States, Australia | Seed, Series A | Software, SaaS, E-Commerce | $1.4M–$16M |
|
K1W1
VC Fund
|
2 | New Zealand, United States | Seed, Series A | Software, Manufacturing, Artificial Intelligence | $520k–$18M |
|
Blackbird Ventures
VC Fund
|
2 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $34k–$35M |
|
ArcAngels
VC Fund
|
1 | New Zealand | Seed, Series A | iOS, Medical, Genetics | |
|
Sante Ventures
VC Fund
|
1 | United States, Canada, Japan | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.9M–$80M |
|
Alt Ventures
VC Fund
|
1 | New Zealand | Seed, Convertible Note | Software, Linux, Security | $1M–$6.4M |
|
Callaghan Innovation
VC Fund
|
1 | New Zealand, United States, Australia | Grant, Pre-Seed, Seed | Manufacturing, Software, Information Technology | $5.9k–$1M |
|
Olympus Corporation of the Americas
VC Fund
|
1 | United States, New Zealand | Grant, Series A, Series C | Medical, Biotechnology, Health Care | |
|
Cure Kids Ventures
VC Fund
|
1 | New Zealand | Seed, Pre-Seed, Series A | Medical Device, Manufacturing, Health Care | $999k–$9.7M |
|
TQ Ventures
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $2.1M–$85M |
|
Hillfarrance Venture Capital
VC Fund
|
1 | New Zealand, United Kingdom | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Gaming | $362k–$2.3M |
|
GD1 (Global From Day One)
VC Fund
|
1 | New Zealand, United States, China | Seed, Series A, Pre-Seed | Software, Information Technology, SaaS | $600k–$16M |
|
Olympus Innovation Ventures
VC Fund
|
1 | Spain | Series B | Medical, Biopharma, Biotechnology | |
|
Bioshore Ventures
VC Fund
|
1 | Australia, New Zealand | Seed, Venture - Series Unknown | Health Care, Medical, Medical Device | |
|
Auckland UniServices
VC Fund
|
1 | New Zealand | Seed, Pre-Seed | Medical, Marketing, Nutrition | |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
Novaquest Capital Management
VC Fund
|
1 | United States, New Zealand, United Kingdom | Private Equity, Series A, Post-IPO Equity | Biotechnology, Health Care, Pharmaceutical | $3.6M–$210M |
|
KP Rx
VC Fund
|
1 | Australia, New Zealand | Seed, Venture - Series Unknown | Health Care, Medical Device, Medical | |
|
AngelHQ
VC Fund
|
1 | New Zealand, United States, Canada | Seed, Angel, Series A | Software, SaaS, Apps | $350k–$19M |
|
Hostplus
VC Fund
|
1 | Australia, United Kingdom, United States | Series A, Series B, Series C | Software, Biotechnology, Semiconductor | $6.3M–$111M |
|
American Gastroenterological Association
VC Fund
|
1 | United States, New Zealand | Series A, Series C | Medical, Health Care, Medical Device | $8M–$18M |
| Access all 44 VC funds in New Zealand Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 252
- Round size: Seed $650k–$4.9M; Series A $2.5M–$19M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Health Care, Medical Device, Manufacturing
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 28
- Round size: Seed $694k–$5M; Pre-Seed $283k–$1.3M; Venture - Series Unknown $3.2M–$8.4M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- RosterLab — RosterLab goal is to automate every part of the rostering process for healthcare.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 20
- Round size: Seed $473k–$2.2M; Pre-Seed $337k–$972k; Series A $2.3M–$25M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Advemto — Advemto is the manufacturer and developer of ultrafast spectroscopy systems that help researchers.
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Captivate Technology — Captivate Technology company operates a clean-tech carbon capture platform. The platform enables cement manufacturers, geothermal power plants, and biogas producers to reduce pollution and contribute to environmental initiatives by using a metal-organic framework for CO2 adsorption as a solid-state material.
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: New Zealand, Australia, United States
Investor stats
- Total investments: 52
- Round size: Seed $900k–$5M; Pre-Seed $511k–$1.6M; Venture - Series Unknown $3.2M–$5.5M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Regen — We send daily recommendations to our farmers' phones based on their own farm data, so NZ can farm smarter.
- Androgenix —
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 206
- Round size: Seed $393k–$8.5M; Series A $2.4M–$30M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Oxa — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Medical Device
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 33
- Round size: Seed $694k–$5M; Series A $1.2M–$18M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Shuttlerock — Create attention-worthy video ads from any asset for every screen, at scale.
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, Information Technology, Medical Device
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 81
- Round size: Seed $694k–$4.9M; Series A $3.5M–$17M; Venture - Series Unknown $435k–$6.1M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Angel
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 134
- Round size: Seed $306k–$4.3M; Angel $229k–$651k
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $12M in 2019
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
Flying Kiwi Angels ? Helping Kiwi Startups
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Angel, Pre-Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 28
- Round size: Seed $334k–$4.3M; Angel $592k–$918k; Pre-Seed $362k–$1.3M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- PAM NZ — Forward a school newsletter, snap a screenshot, brain-dump your to-do list - PAM turns it all into a smart shared family calendar and helps manage the family tasks and events. Set up in 2 minutes. Free trial.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 67
- Round size: Seed $1.4M–$4.9M; Series A $1.5M–$16M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $125M in 2022
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- LawVu — Our all-in-one connected platform enables your legal team to manage all legal matters, contracts, spend and legal operations. Book your free demo now.
- Migco Pharmaceuticals — Migco Pharmaceuticals is a pharmaceutical company focused on designed to develop new drug therapies for migraine headache.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, Manufacturing, Artificial Intelligence
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 116
- Round size: Seed $734k–$4.1M; Series A $520k–$18M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Linca — Critical metals for a circular battery supply chain
- Hyades — Hyades is an AI-powered hyperspectral intelligence platform that offers soil and land insights.
- Appetise — MenuAid is a cheaper, flexible and more sustainable alternative to meal-kit delivery providers. We provide Kiwis with a weekly meal plan, complete with recipes and a list of ingredients that can either be self-shopped or collected/delivered from your favourite supermarkets.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 337
- Round size: Seed $34k–$7.6M; Pre-Seed $50k–$2.7M; Series A $3.4M–$35M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Vow — Vow is crafting a new category of food
- Partly — Auto parts distributors, manufacturers, dismantlers, marketplaces and software providers use Partly's software and API to add fitment and manage parts online.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
At ArcAngels Funding, we connect female entrepreneurs across New Zealand to venture capital and investment to help their businesses grow.
Show more...Investment focus
- Industry: iOS, Medical, Genetics
- Stage:Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VidApp — VidApp makes it easy to build, design and launch your own mobile and tv apps. Connect your current website or channel and build your audience today.
- Grater Goods — Grater Goods is a food and beverage manufacturing company that aims to provide customers with gourmet plant based deli items.
- Engender Technologies — Engender has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells, enabling dairy farmers to accelerate genetic gain and improve productivity. Engender has secured scientific and laboratory facilities from one of the world’s largest AI companies in exchange for an option for it to non-exclusively licenseEngender’s technology.
Privately Held Companies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Japan
Investor stats
- Total investments: 119
- Round size: Series A $1.9M–$32M; Series B $2.6M–$48M; Series C $5M–$80M
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely still investing — raised $260M in 2021
Portfolio highlights
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- REVELOHEALTH — REVELOHEALTH provides advisory services. Their services include healthcare provider solutions, revenue cycle solutions, price transparency solutions, payment integrity, network claim repricing, data analytics, denial management, and direct-to-employer.
- Sonire Therapeutics — SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a noveltherapeutic modality with the goal of giving cancer patients and their families a new future.
AmpliPHI Ventures provides wholesale investors access to the private market investment opportunities.
Show more...Investment focus
- Industry: Software, Linux, Security
- Stage:Seed, Convertible Note
- Geography: New Zealand
Investor stats
- Total investments: 6
- Round size: Seed $1M–$6.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Arcanum AI — Rapidly build and integrate machine learning features with the Accelerate Platform library of pre-built workflows. Hosted API or deploy into your own cloud.
- Goodair Nosebuds — Goodair Nosebuds develops mechanical breathing technology to restore natural nasal functioning. It specializes in gently massaging upper airways using air, stimulating the body's natural defense system, and improving airway clarity, enabling users to enhance their well-being by balancing airway hydration.
- Sandfly Security — Sandfly is an agentless Linux EDR and incident response platform. Sandfly finds Linux threats without endpoint agents.
Callaghan Innovation is a stand-alone Crown Entity established on 1 February, 2013. Their role hasn’t previously existed in New Zealand.When they succeed, all New Zealanders will benefit from a stronger economy, higher value exports, more productive and sustainable resource use, more jobs and higher incomes.International evidence showsadvanced technology institutes like Callaghan Innovation have been successful at helping businesses build innovation capability that contributes to their growth and the broader economy.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Grant, Pre-Seed, Seed
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 922
- Round size: Seed $593k–$1M; Grant $5.9k–$39k; Pre-Seed $607k–$716k
- Lead/follow: 98% lead, 2% follow
Portfolio highlights
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Wallo Pay — Wallo Pay, incorporated in July 2023, is a New Zealand-based fintech startup transforming digital payments for consumers and businesses. Operating across Aotearoa and with plans to expand into Australia, our founder-led team is building a B2C and B2B payments platform powered by banking APIs, enabling direct, real-time account-to-accounttransactions. By bypassing traditional card networks, Wallo Pay slashes merchant service fees from 1.5–2.5% to 0.6% or less, potentially saving New Zealand businesses $700M annually. Our product suite includes a Consumer Mobile App with QR-based and unique digital ID based payments, a Business Mobile App, and a Business Web Portal, targeting retail, hospitality, and other businesses accepting payments from end customers.Aligned with New Zealand’s Consumer Data Right (2025), Wallo Pay’s open API infrastructure empowers developers, fintech startups, and public agencies to build innovative solutions, from loyalty programs to interoperable transport payments. Our platform fosters an inclusive ecosystem, enabling business of all sizes and innovators to participate in the digital economy with low-cost, scalable payment tools. Since starting MVP development in June 2024, Wallo Pay is gearing up for an alpha pilot in Q3–Q4 2025, driving transparency, affordability, and trust in Aotearoa’s payment landscape.
- Forever Harvest — Forever Harvest is a food technology startup specializing in cellular horticulture.
At Olympus, we put a lot of good back into the world, and what we do, really matters.
Show more...Investment focus
- Industry: Medical, Biotechnology, Health Care
- Stage:Grant, Series A, Series C
- Geography: United States, New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Swan EndoSurgical — Swan EndoSurgical provides endoluminal surgical robotic systems that will enhance patient care everywhere.
- On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood Impact investing since 2008 Portfolio Companies Invested Health Tech Products Launched Product and Service Revenue Generated Jobs Created in NZ Paediatric Patients
Show more...Investment focus
- Industry: Medical Device, Manufacturing, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 12
- Round size: Seed $999k–$9.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- ISpy Nits — ISpyNits - everything you need to get rid of lice and nits once and for all
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Led by Schuster Tanger, Andrew Marks, and Scooter Braun, TQ Ventures is a leading venture capital firm based in New York City and Los Angeles.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 196
- Round size: Seed $2.1M–$15M; Series A $7.3M–$50M; Series B $20M–$85M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Augmodo — Augmodo Spatial AI enables real-time tracking of products across all stores, enhancing inventory management and shopping experiences. It discovers information through augmented reality for enhanced experiences.
- Copperlane — AI-Native Mortgage Origination Software. Powering the Path Home. Backed by @ycombinator
- Architect — Architect Labs builds AI systems that design and provably verify silicon for modern workloads.
We exist to serve great entrepreneurs with honest advice and education, investment capital that is fair, and an open door to our international network and connections.
Show more...Investment focus
- Industry: Software, Information Technology, Gaming
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $618k–$2.3M; Pre-Seed $362k–$1.2M; Venture - Series Unknown $900k–$2.1M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Kyoryu — Re-engineered dinosaurs roam a post-apocalyptic Japan. Follow the Samurai T-rex clan as they navigate complex dino clan rivalries.
- RiffRaff Games — Developers of Sleight of Hand
- Space Rock Games — Space Rock Games is the developer behind Criminals Within - a cooperative-only action game set in a medieval fantasy kingdom. Sign up to receive exclusive development updates!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 68
- Round size: Seed $600k–$8.2M; Pre-Seed $860k–$11M; Series A $1.8M–$16M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Vessev — Electric hydrofoiling vessels built for commercial use. Quiet, efficient, and better for the world.
- Caruso — AI-native fund administration for private markets. Trusted by 900+ real estate, private credit, and PE funds to save time and grow AUM.
- Outlier Space — Outlier Space is an aerospace startup that builds a scalable, uncrewed, and reusable satellite platform designed to unlock access to microgravity. The company provides breakthrough infrastructure to safely return orbital payloads back to Earth. This technology allows sectors like pharmaceuticals, biotechnology, and advanced materials to manufactureand research products beyond Earth's atmospheric limits.
Olympus Innovation Ventures is an investment firm.
Show more...Investment focus
- Industry: Medical, Biopharma, Biotechnology
- Stage:Series B
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Universal Diagnostics — Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early.The UDX diagnosticplatform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis.UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I).To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.
Bioshore Ventures is an Australian venture capital firm focused on early-stage medical technology and biotech investments. The firm addresses a funding gap in Australia's strong medtech R&D ecosystem by providing specialized risk capital to commercialize innovative healthcare technologies.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vexev — Vexev is on a mission to introduce innovative imaging diagnostic tools.
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
UniServices grows and commercialises the research and expertise of the University of Auckland to create real-world impact.
Show more...Investment focus
- Industry: Medical, Marketing, Nutrition
- Stage:Seed, Pre-Seed
- Geography: New Zealand
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Opo Bio — Opo Bio develops cell lines for the cultivated meat industry and researchers.They are building a multi-species and multi-cell type product bank for research and commercial usage. They are creating infrastructure that will enable the industry to progress and more effectively scale.
- PhaseFoam — Cold chain solutions
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 219
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- Protego Biopharma — Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.
- Twentyeight-Seven Therapeutics — Maxslot88 merupakan link situs slot gacor gampang menang jackpot maxwin hari ini sebagai daftar apk slot88 terpercaya dengan server thailand resmi, memberikan pengalaman bermain slot online yang aman dan menghibur bagi semua klien.
About NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and gro...
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Private Equity, Series A, Post-IPO Equity
- Geography: United States, New Zealand, United Kingdom
Investor stats
- Total investments: 32
- Round size: Series A $3.6M–$210M; Private Equity $5.3M–$200M; Post-IPO Equity $50M–$125M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $275M in 2019
Portfolio highlights
- Mirna — Soon to be launched, our AI-powered MI:RNA platform is designed to detect a range of diseases prior to the development of clinical signs. This groundbreaking
- Mileutis — At Mileutis, we focus on discovery, development and commercialization of novel and biologically sourced, safe and residue free therapies for animal health.
- Gallant — Gallant is developing a scalable stem cell therapy platform that will allow any veterinarian to routinely treat pets in a primary care setting, improving the lives of pets and their people. By systematically addressing challenges that previously hindered stem cell therapy adoption, the company aims to make stem cell products accessible in order toelevate the quality of life for all pets and the people that love them.
KP Rx is a 100% founder-owned investment firm focusing on private and early-stage public healthcare investments in Australia and New Zealand.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
- Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Learn about Angel HQ, Wellington's Angel Investing Network - the meeting place for ambitious startups and passionate investors.
Show more...Investment focus
- Industry: Software, SaaS, Apps
- Stage:Seed, Angel, Series A
- Geography: New Zealand, United States, Canada
Investor stats
- Total investments: 40
- Round size: Seed $350k–$3M; Angel $367k–$1M; Series A $6.1M–$19M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Luminoma — Luminoma will enable easy access to objective and precise skin cancer screening. With Luminoma, clinicians can confidently discern malignant from benign, reducing unnecessary referrals and biopsies.
- Upstock — Manage wholesale orders with a simple app.
- Factor — Plug and play forecasting and pricing tools for modern energy utilities.
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more...Investment focus
- Industry: Software, Biotechnology, Semiconductor
- Stage:Series A, Series B, Series C
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 63
- Round size: Series A $6.3M–$49M; Series B $20M–$111M; Series C $13M–$60M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Emesent — Solutions for GPS-denied environments - delivering revolutionary efficiency, safety and operational insights to underground mining and other industries.
- Gradiant — Gradiant is a solutions provider and developer of cleantech water projects for advanced water and wastewater treatment. They provide microelectronics, pharmaceuticals, food and beverage, lithium and key minerals, and renewable energy.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Our mission is to empower clinicians and researchers to improve digestive health. Also follow @AGA_Gastro @AGA_CGH @AGA_CMGH @AGA_TIGE @AGA_GHAdvances @AGA_GIHN
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A, Series C
- Geography: United States, New Zealand
Investor stats
- Total investments: 3
- Round size: Series A $8M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alimetry — Gastric Alimetry brings data-driven clarity to chronic gastric symptoms, helping clinicians diagnose with confidence.
- Oshi Health — Oshi Health is a virtual-first gastroenterology (GI) clinic that diagnoses, treats and remotely monitors digestive (GI) conditions. Patients work with Oshi Health's integrated care team of gastroenterologists and GI-specialized nurse practitioners, registered dietitians, behavioral psychologists and health coaches to determine the root causesof their symptoms and use a personalized care plan that includes medication, dietary interventions and stress/anxiety reduction to get symptoms under control. This yields improved health outcomes, quality of life, satisfaction with care and workplace productivity while reducing overall healthcare cost.
- Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
Medical VC funding in New Zealand at a glance
Stats across 104 deals from 44 investors.
Access all 44 VC funds in New Zealand Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in New Zealand investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 44 VC funds investing in New Zealand Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!